NDC 0010-3701-01 - Buscopan

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0010-3701
Requested NDC: 0010-3701-01
Package NDCs from labels: 0010-3701-01
Manufacturer: Boehringer Ingelheim Animal Health USA Inc.
Effective date: 2026-05-18
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Buscopan® Injectable Solution (N-butylscopolammonium bromide) 20 mg/mL	Boehringer Ingelheim Animal Health USA Inc.	2026-05-18	PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0010-3701-01	Buscopan	50 mL in 1 VIAL	INJECTION	50		8
0010-3701-01	Buscopan	1 in 1 CARTON	INJECTION	1		8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0010-3701	BUSCOPAN (N-BUTYLSCOPOLAMMONIUM BROMIDE) INJECTION [BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.]	7	2 package rows	20250330_858926e9-457e-47c2-b7c4-2d1c6bb13ea8.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BUTYLSCOPOLAMINE BROMIDE	ACTIVE INGREDIENT	0GH9JX37C8	BUSCOPAN (N-BUTYLSCOPOLAMMONIUM BROMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]	2
BUTYLSCOPOLAMINE	ACTIVE MOIETY	2Z3E1OF81V	BUSCOPAN (N-BUTYLSCOPOLAMMONIUM BROMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	BUSCOPAN (N-BUTYLSCOPOLAMMONIUM BROMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	BUSCOPAN (N-BUTYLSCOPOLAMMONIUM BROMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]	2
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	BUSCOPAN (N-BUTYLSCOPOLAMMONIUM BROMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	BUSCOPAN (N-BUTYLSCOPOLAMMONIUM BROMIDE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 44 of 44 · 869 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Female Vitality T010	CIMICIFUGA RACEMOSA, FUCUS VESICULOSUS, OOPHORINUM (SUIS), HYPOPHYSIS SUIS, THYROIDINUM (SUIS), GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), SEPIA	Guangzhou Renuma Medical Systems Co., Ltd	694f0c36-b656-471a-9f38-2efb5193e05a	2017-10-20	Warnings	Exact identifier unii: 451W47IQ8X
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Company	886f889b-f3cf-4197-b307-6cfa88c89436	2017-05-04		Exact identifier unii: 451W47IQ8X
ReHydration	ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, NATRUM MURIATICUM, SARSAPARILLA, SILICEA, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE)	Energetix Corp	9883c502-9782-451e-9eec-c54d7b054f31	2017-01-31	Warnings	Exact identifier unii: 451W47IQ8X
Tox-Chord	ALFALFA, ALUMINA, BENZOICUM ACIDUM, CARBONEUM, CETRARIA ISLANDICA, FOLLICULINUM, FUCUS VESICULOSUS, FUMARICUM ACIDUM, HEPAR SUIS, KALI CARBONICUM, KREOSOTUM, NATRUM MURIATICUM, PARAFFINUM, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PIX LIQUIDA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PULSATILLA (VULGARIS), RADIUM BROMATUM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM OFFICINALE, TABACUM, TEREBINTHINA, THYROIDINUM (BOVINE), TRITICUM REPENS, ZINCUM OXYDATUM	Energetix Corp	6b0d1628-b20d-426e-9c84-5cceadca3f45	2016-11-11	Warnings	Exact identifier unii: 451W47IQ8X
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Corporation	2a96096d-43cc-49b7-af53-b53c17f41001	2014-07-25	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
SODIUM CHLORIDE	SODIUM CHLORIDE	Baxter Healthcare Corporation	b3b4b176-41f0-4ca8-90d4-3fba5707564a	2014-02-21		Exact identifier unii: 451W47IQ8X
TIS-U-SOL	SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE	Baxter Healthcare Corporation	9da4121f-d62d-4da4-8dfb-0494da16015f	2014-02-21		Exact identifier unii: 451W47IQ8X
Ringers	SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE,	Baxter Healthcare Corporation	e1953d54-818d-46a6-8532-518ebae6d84e	2012-06-13		Exact identifier unii: 451W47IQ8X
Lactated Ringers	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	Baxter Healthcare Corporation	f09f80bf-2f8b-4420-865d-aec2d5e5cd4d	2012-06-12		Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.